Associations of serum uric acid with incident dementia and cognitive decline in the ARIC-NCS cohort
- PMID: 32387846
- PMCID: PMC7293945
- DOI: 10.1016/j.jns.2020.116866
Associations of serum uric acid with incident dementia and cognitive decline in the ARIC-NCS cohort
Abstract
Introduction: Elevated serum uric acid (SUA) is associated with cardiovascular risk factors, which often contribute to dementia and dementia-like morbidity, yet several cross-sectional studies have shown protective associations with cognition, which would be consistent with other work showing benefits of elevated SUA through its antioxidant properties.
Methods: We studied 11,169 participants free of dementia and cardiovascular disease from the Atherosclerosis Risk in Communities (ARIC) cohort. SUA was measured in blood samples collected in 1990-92, baseline for this study (age range 47-70 years). Incident dementia was ascertained based on clinical assessments in 2011-13 and 2016-17, surveillance based on dementia screeners conducted over telephone interviews, hospitalization discharge codes, and death certificates. Cognitive function was assessed up to four times between 1990 and 92 and 2016-17. We estimated the association of SUA, categorized into quartiles, with incidence of dementia using Cox regression models adjusting for potential confounders. The association between cognitive decline and SUA was assessed using generalized estimating equations.
Results: Over a median follow-up period of 24.1 years, 2005 cases of dementia were identified. High baseline SUA was associated with incident dementia (HR, 1.29; 95% CI, 1.12, 1.47) when adjusted for sociodemographic variables. However, after further adjustment including cardiovascular risk factors, this relationship disappeared (HR, 1.03; 95% CI, 0.88, 1.21). Elevated baseline SUA was associated with faster cognitive decline even after further adjustment (25-year global z-score difference, -0.149; 95% CI, -0.246, -0.052).
Conclusion: Higher levels of mid-life SUA were associated with faster cognitive decline, but not necessarily with higher risk of dementia.
Keywords: Cognitive decline; Cohort study; Dementia; Epidemiology; Uric acid.
Copyright © 2020 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no conflicts of interest.
Figures
Similar articles
-
Associations Between Midlife Vascular Risk Factors and 25-Year Incident Dementia in the Atherosclerosis Risk in Communities (ARIC) Cohort.JAMA Neurol. 2017 Oct 1;74(10):1246-1254. doi: 10.1001/jamaneurol.2017.1658. JAMA Neurol. 2017. PMID: 28783817 Free PMC article.
-
Association of Atrial Fibrillation With Cognitive Decline and Dementia Over 20 Years: The ARIC-NCS (Atherosclerosis Risk in Communities Neurocognitive Study).J Am Heart Assoc. 2018 Mar 7;7(6):e007301. doi: 10.1161/JAHA.117.007301. J Am Heart Assoc. 2018. PMID: 29514809 Free PMC article.
-
Mid-life serum Vitamin D concentrations were associated with incident dementia but not late-life neuropsychological performance in the Atherosclerosis Risk in Communities (ARIC) Study.BMC Neurol. 2019 Oct 22;19(1):244. doi: 10.1186/s12883-019-1483-3. BMC Neurol. 2019. PMID: 31640594 Free PMC article. Clinical Trial.
-
B vitamins and prevention of cognitive decline and incident dementia: a systematic review and meta-analysis.Nutr Rev. 2022 Mar 10;80(4):931-949. doi: 10.1093/nutrit/nuab057. Nutr Rev. 2022. PMID: 34432056
-
Influence of Uric Acid on Vascular and Cognitive Functions: Evidence for an Ambivalent Relationship.Metabolites. 2024 Nov 20;14(11):642. doi: 10.3390/metabo14110642. Metabolites. 2024. PMID: 39590878 Free PMC article. Review.
Cited by
-
Associations of serum uric acid variability with neuroimaging metrics and cognitive decline: a population-based cohort study.BMC Med. 2024 Jun 20;22(1):256. doi: 10.1186/s12916-024-03479-9. BMC Med. 2024. PMID: 38902722 Free PMC article.
-
Mechanistic insights of soluble uric acid-induced insulin resistance: Insulin signaling and beyond.Rev Endocr Metab Disord. 2023 Apr;24(2):327-343. doi: 10.1007/s11154-023-09787-4. Epub 2023 Jan 30. Rev Endocr Metab Disord. 2023. PMID: 36715824 Review.
-
Machine learning-based prediction models for renal impairment in Chinese adults with hyperuricaemia: risk factor analysis.Sci Rep. 2025 Mar 15;15(1):8968. doi: 10.1038/s41598-025-88632-x. Sci Rep. 2025. PMID: 40089508 Free PMC article.
-
Moderate increase of serum uric acid within a normal range is associated with improved cognitive function in a non-normotensive population: A nationally representative cohort study.Front Aging Neurosci. 2022 Sep 1;14:944341. doi: 10.3389/fnagi.2022.944341. eCollection 2022. Front Aging Neurosci. 2022. PMID: 36118682 Free PMC article.
-
Gout/hyperuricemia reduces the risk of Alzheimer's disease: A meta-analysis based on latest evidence.Brain Behav. 2023 Oct;13(10):e3207. doi: 10.1002/brb3.3207. Epub 2023 Sep 4. Brain Behav. 2023. PMID: 37667521 Free PMC article.
References
-
- Duron E, Hanon O. Antihypertensive treatments, cognitive decline, and dementia. J Alzheimers Dis. 2010;20(3):903–14. - PubMed
-
- Yap YW, Whiteman M, Cheung NS. Chlorinative stress: an under appreciated mediator of neurodegeneration? Cell Signal. 2007;19(2):219–28. - PubMed
-
- Palmer AM. The blood-brain barrier. Neurobiol Dis. 2010;37(1):1–2. - PubMed
MeSH terms
Substances
Grants and funding
- U01 HL096812/HL/NHLBI NIH HHS/United States
- U01 HL096902/HL/NHLBI NIH HHS/United States
- HHSN268201700002C/HL/NHLBI NIH HHS/United States
- HHSN268201700001I/HL/NHLBI NIH HHS/United States
- U01 HL096814/HL/NHLBI NIH HHS/United States
- R01 HL070825/HL/NHLBI NIH HHS/United States
- HHSN268201700003I/HL/NHLBI NIH HHS/United States
- P30 AG066511/AG/NIA NIH HHS/United States
- U01 HL096917/HL/NHLBI NIH HHS/United States
- K24 HL148521/HL/NHLBI NIH HHS/United States
- HHSN268201700004I/HL/NHLBI NIH HHS/United States
- HHSN268201700005C/HL/NHLBI NIH HHS/United States
- HHSN268201700001C/HL/NHLBI NIH HHS/United States
- HHSN268201700003C/HL/NHLBI NIH HHS/United States
- U01 HL096899/HL/NHLBI NIH HHS/United States
- HHSN268201700004C/HL/NHLBI NIH HHS/United States
- HHSN268201700002I/HL/NHLBI NIH HHS/United States
- HHSN268201700005I/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical